Corporate ActionJun 3, 2026, 08:02 AM
Radiopharm Theranostics Announces Cessation of 505,598 Options
AI Summary
Radiopharm Theranostics Limited announced the cessation of 505,598 unquoted options (ASX code RADAN) due to their expiry without exercise or conversion. The options ceased on May 31, 2026, and the company did not pay any consideration for this cessation. Following this corporate action, the company's issued capital has been updated, reflecting the reduced number of outstanding unquoted options.
Key Highlights
- Radiopharm Theranostics announced the cessation of securities.
- A total of 505,598 unquoted options (RADAN) ceased.
- Cessation occurred due to expiry without exercise or conversion.
- The options ceased on May 31, 2026.
- No consideration was paid by the entity for the cessation.
- Remaining unquoted options (RADAN) now total 421,025,268.
Price Impact
More from RADX